Type 1 diabetes trials in China

In China 40 Also abroad 551

29 of 40 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Where
Beijing, Changchun, Changsha, Chengdu, Guangzhou, Hangzhou, Harbin, Hohhot, Jinan, Lanzhou, Luoyang, Nanchang, Nanjing, Pingxiang, Shanghai, Shenyang, Shenzhen, Tianjin, Wuhan, Wuxi, Yueyang, Zhengzhou, Zhenjiang
Age
1 year to 25 years
People
723 worldwide
Run by
Sanofi
See details and how to joinNCT07088068
Phase 3Not yet taking people in China
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Where
Beijing, Changchun, Chengdu, Guangzhou, Huzhou, Nanjing, Ningbo
Age
18 years and over
People
500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00
Phase 3Not yet taking people in China
A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
Where
Beijing, Bozhou, Cangzhou, Changzhou, Chongqing, Daqing, Ganzhou, Guangzhou, Jiaxing, Jinan, Liuzhou, Luoyang, Luzhou, Sanya, Shanghai, Shenyang, Shiyan, Suzhou, Wuhan, Xi'an, Xuancheng, Yuncheng, Zhengzhou
Age
18 years and over
People
330 worldwide
Run by
AstraZeneca
See details and how to joinNCT07922330
Phase 3Not yet taking people in China
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Beijing, Cangzhou, Changchun, Changsha, Chengdu, Danyang, Ganzhou, Guiyang, Hengshui, Huizhou, Lanzhou, Panjin, Qiqihar, Shanghai, Suzhou, Xiamen, Xianyang, Zigong
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
Phase 2Not yet taking people in China
JAK1 Inhibitor Ivarmacitinib for Improving Pancreatic Islet Function in T1D
Where
Shanghai
Age
10 years to 40 years
People
132
Run by
Huijie Zhang
See details and how to joinNCT07845955
No phaseTaking people
Effect of Different Carbohydrate Intake Patterns on Glycemic Control in Patients With Type 1 Diabetes
Where
Nanjing
Age
18 years to 70 years
People
80
Run by
Yang Tao
See details and how to joinNCT06273631
Phase 1Taking people
Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity
Where
Kunming
Age
18 years to 50 years
People
36
Run by
Shanghai Minwei Biotechnology Co., Ltd
See details and how to joinNCT07803809
Phase 3Not yet taking people in China
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Where
Beijing, Cangzhou, Changchun, Changde, Changzhou, Chengdu, Chongqing, Hefei, Huzhou, Jilin City, Jinan, Kaifeng, Langfang, Luoyang, Nanjing, Nanyang, Panjin, Shanghai, Shenzhen, Shijiazhuang, Shiyan, Suzhou, Xining, Zhengzhou, Zhenjiang
Age
45 years and over
People
1,778 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07797335
Early phase 1Enrolling by invitation
An Exploratory Clinical Study Evaluating Allogeneic iPSC-derived Pancreatic Islet Cells (CRG-002) for the Treatment of Diabetic Patients With Hypoglycemia Unawareness or Severe Hypoglycemic Events
Where
Hefei
Age
18 years to 70 years
People
10
Run by
Celregen Therapeutics
See details and how to joinNCT07503028
No phaseTaking people
Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System
Where
Zibo
Age
18 years and over
People
36
Run by
SiBionics, Co, Ltd
See details and how to joinNCT07745244
No phaseTaking people
AI-Assisted Remote Insulin Pump Optimization in T1DM
Where
Nanjing
Age
14 years to 65 years
People
50
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07732777
Phase 2/3Taking people
Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes
Where
Nanjing
Age
18 years to 65 years
People
96
Run by
Nanjing Medical University
See details and how to joinNCT07548996
Early phase 1Taking people
Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes
Where
Shanghai
Age
18 years to 40 years
People
9
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT07528105
No phaseTaking people
Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM
Where
Shanghai
Age
Up to 18 years
People
50
Run by
Children's Hospital of Fudan University
See details and how to joinNCT03835312
No phaseTaking people
Intervention for Children With Type 1 Diabetes Targeting Gut Microbes
Where
Shanghai
Age
6 years to 12 years
People
110
Run by
Children's Hospital of Fudan University
See details and how to joinNCT06198725
Phase 3Taking people
Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus
Where
Nanjing
Age
18 years to 65 years
People
90
Run by
Nanjing Medical University
See details and how to joinNCT07258394
Phase 1Taking people
MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
Where
Changsha, Chengdu, Shanghai
Age
18 years and over
People
45
Run by
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.
See details and how to joinNCT04187443
Phase 1Taking people
Phase I Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 1 Diabetes Mellitus
Where
Tianjin
Age
18 years to 60 years
People
10
Run by
Hangzhou Reprogenix Bioscience, Inc
See details and how to joinNCT06731218
No phaseTaking people
Study on the Improvement of Metabolic Indicators in Type 1 Diabetes Patients
Where
Beijing
Age
18 years and over
People
150
Run by
Peking University First Hospital
See details and how to joinNCT07144696
No phaseTaking people
Efficacy of Glycemic Improvement Project (GLITTER Study) in Type 1 Diabetes-GLITTER Study 2
Where
Beijing, Changsha, Chengdu, Hangzhou, Luoyang, Quanzhou, Shenyang, Shenzhen, Tangshan, Wuhan
Age
6 years and over
People
400
Run by
Second Xiangya Hospital of Central South University
See details and how to joinNCT07097818
Phase 1/2Taking people
A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes
Where
Shanghai
Age
18 years to 75 years
People
21
Run by
EndoCell Therapeutics, Inc.
See details and how to joinNCT07126873
No phaseTaking people
Glycemic Improvement With Team, Technology, Education and Peer Resources in Type 1 Diabetes-GLITTER Study
Where
Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Luoyang, Nanjing, Shenyang, Shenzhen
People
3,000
Run by
Second Xiangya Hospital of Central South University
See details and how to joinNCT07097805
No phaseTaking people
Clinical Study on the Treatment of Type 1 Diabetes With CNK-UT009 Cell Injection
Where
Zibo
Age
18 years to 65 years
People
12
Run by
Zibo Central Hospital
See details and how to joinNCT07051564
No phaseNot yet taking people in China
Evaluating an Insulin Pump for Time in Range (TIR) in Patients with Type 1 Diabetes
Where
Beijing
Age
8 years to 75 years
People
60
Run by
Tao Yuan，MD
See details and how to joinNCT06741943
Phase 1Taking people
Immunotherapy with Autologous Tregs in T1DM
Where
Nanjing
Age
8 years to 65 years
People
20
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT06708780